The present invention discloses a dimeric polypeptide radiopharmaceutical targeting integrin α6 and a preparation method thereof. The radiopharmaceutical comprises a cKiE dimer polypeptide and a radionuclide, wherein the radionuclide is labeled with the cKiE dimer polypeptide through a bifunctional chelating agent; the cKiE dimer polypeptide is dimerized by two cKiE polypeptide monomers connected by a linker; the cKiE polypeptide monomer is a cyclic polypeptide, and the cyclic polypeptide is composed of an amino acid molecular chain with the sequence of Lys-Arg-Trp-Tyr-Asp-Glu-Asn-Ala-Glu connected head to tail; the linker is an amino acid molecular chain in which 3-5 inert amino acid molecules are sequentially connected or a polyethylene glycol with a polymerization degree of 3-12, and the inert amino acid is glycine or serine. The cyclic polypeptide sequence of the radiopharmaceutical of the invention will not be recognized by proteases in vivo, and can effectively improve the in vivo metabolic stability, thereby improving the uptake of tumor tissue.
This patent application describes a dimeric polypeptide radiopharmaceutical targeting integrin α6. It comprises a cKiE dimeric polypeptide and a radionuclide, with the radionuclide attached through a bifunctional chelator; the cKiE monomer is a cyclic peptide with the amino acid sequence Lys-Arg-Trp-Tyr-Asp-Glu-Asn-Ala-Glu.
The application also describes preparation methods using HYNIC or DOTA chelators and radionuclides such as 99mTc or 68Ga, and states that the radiopharmaceutical is used to prepare an imaging diagnostic agent for patients with integrin α6-positive tumors. This manual is written in Chinese.
| cKiE monomer sequence | Lys-Arg-Trp-Tyr-Asp-Glu-Asn-Ala-Glu |
|---|---|
| Linker | 3-5 inert amino acids or polyethylene glycol with degree of polymerization 3-12 |
| Inert amino acids | Glycine or serine |
| Radionuclides | 99mTc, 68Ga, 64Cu, 111In, 90Y, or 177Lu |
| Bifunctional chelators | HYNIC, DOTA, NOTA, or DTPA |
| Linker examples | GGG, SSS, GSS, GGS, GSG, GGGG, or GGGGG |
| Polyethylene glycol linker | Degree of polymerization 4 |
| Pharmacokinetic modifier | Polyethylene glycol with degree of polymerization 4 or 8-aminooctanoic acid |
| Physical form | Colorless transparent liquid injection |
| Intended use | Imaging diagnostic agent for patients with integrin α6-positive tumors |
The cyclic peptide monomer has the sequence Lys-Arg-Trp-Tyr-Asp-Glu-Asn-Ala-Glu.
The radionuclide can be 99mTc, 68Ga, 64Cu, 111In, 90Y, or 177Lu.
It is used to prepare an imaging diagnostic agent for patients with integrin α6-positive tumors.
The polypeptide radiopharmaceutical is described as a colorless transparent liquid injection.